SaddleRock Capital Management LLC Purchases New Stake in Sotera Health Company $SHC

SaddleRock Capital Management LLC acquired a new position in shares of Sotera Health Company (NASDAQ:SHC) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 306,553 shares of the company’s stock, valued at approximately $5,441,000. Sotera Health accounts for approximately 5.3% of SaddleRock Capital Management LLC’s portfolio, making the stock its 10th largest position. SaddleRock Capital Management LLC owned approximately 0.11% of Sotera Health as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Empowered Funds LLC grew its stake in shares of Sotera Health by 11.1% during the 1st quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after purchasing an additional 2,845 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Sotera Health by 14.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock valued at $3,999,000 after purchasing an additional 43,471 shares during the period. Acadian Asset Management LLC lifted its stake in shares of Sotera Health by 125.5% in the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after purchasing an additional 14,018 shares during the period. Creative Planning boosted its holdings in Sotera Health by 15.3% during the second quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after buying an additional 2,673 shares in the last quarter. Finally, Invesco Ltd. boosted its holdings in Sotera Health by 4.2% during the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after buying an additional 12,758 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $19.17 on Tuesday. The business’s fifty day moving average price is $17.82 and its two-hundred day moving average price is $16.35. The stock has a market cap of $5.47 billion, a PE ratio of 33.63 and a beta of 1.77. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. Sotera Health Company has a one year low of $13.09 and a one year high of $19.85.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. During the same quarter last year, the business posted $0.20 earnings per share. Sotera Health’s revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, analysts forecast that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Barclays increased their target price on shares of Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Citigroup boosted their price target on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. UBS Group set a $19.00 price target on Sotera Health in a report on Wednesday, June 24th. The Goldman Sachs Group assumed coverage on Sotera Health in a research note on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective for the company. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and a consensus target price of $21.50.

Insider Transactions at Sotera Health

In related news, Chairman Michael B. Jr. Petras sold 850,000 shares of Sotera Health stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the sale, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Michael P. Rutz sold 150,000 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the transaction, the insider directly owned 334,279 shares of the company’s stock, valued at $6,297,816.36. The trade was a 30.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. 15.36% of the stock is currently owned by company insiders.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.